memory and cognition

April 2, 2019

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA AK027294 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 2/April/2019, 6.50 am

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA AK027294 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 2/April/2019, 6.50 am https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-AK027294-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-AK027294-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg April 2, 2019 April 2, 2019

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

April 1, 2019

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA 00152 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 1/April/2019, 11,51 pm

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA 00152 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 1/April/2019, 11,51 pm https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-00152-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-00152-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg April 1, 2019 April 1, 2019

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

March 31, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA 00152 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 31/March/2019, 8.50 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA 00152 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 31/March/2019, 8.50 am https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-00152-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-00152-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg March 31, 2019 March 31, 2019

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA; Paul F. Glenn Center for the Biology of…

March 29, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA GM6135 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 29/March/2019, 10.41 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA GM6135 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 29/March/2019, 10.41 am https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-GM6135-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-GM6135-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg March 29, 2019 March 29, 2019

March 28, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA B3GALT5-AS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 28/March/2019, 7.07 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA B3GALT5-AS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 28/March/2019, 7.07 am https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-B3GALT5-AS1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-B3GALT5-AS1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg2_.jpg2_.jpg March 28, 2019 March 28, 2019

March 28, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA PMS2L2 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 28/March/2019, 5.58 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA PMS2L2 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 28/March/2019, 5.58 am https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-PMS2L2-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/03/LncRNA-PMS2L2-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory-through-up-regulation-of-its-target-gene-TIMP2-and-BDNF.jpg March 28, 2019 March 28, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA 00152 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 31/March/2019, 8.50 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA GM6135 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 29/March/2019, 10.41 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA B3GALT5-AS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 28/March/2019, 7.07 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA PMS2L2 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 28/March/2019, 5.58 am

Popular Post